SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Apr 2015 07:00

RNS Number : 6595J
Victrex PLC
09 April 2015
 



 

 

 

 

 

9 April 2015

Victrex plc

Half year and pre-close trading update

'A good first half; well positioned for full year progress'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its half year and pre-close trading update for the six months ended 31 March 2015.

Overall, Victrex delivered a good first half performance. Group revenue of £130.3m was 9% ahead of the prior year (H1 2014: £119.9m), with Group sales volume of 2,028 tonnes 28% ahead of the prior year (H1 2014: 1,584 tonnes). The first half performance reflects a continuing positive contribution from Consumer Electronics and slightly lower sales in our Invibio medical business. Group gross margins saw improvement compared to the first half of 2014, reflecting better manufacturing efficiencies.

In Victrex Polymer Solutions (VPS), lower sales into oil and gas were offset by growth in our other markets. Commissioning of the first production stream on our third PEEK manufacturing plant is now complete and successfully started up on schedule. In Invibio, performance reflected the impact from industry consolidation in the US during Q1, as previously communicated, although we saw an improvement in Q2. Invibio revenue of £25.9m was 4% down on the prior year (H1 2014: £26.9m) and flat in constant currency, although our focus remains on continued improvement as we enter the second half.

The adverse currency impact seen by the Group during the first half will also continue into the second half. However, as previously communicated, we continue to expect that we will fully overcome the currency impact for the full year.

David Hummel, Chief Executive of Victrex, said: "Victrex delivered a good first half performance overall. Although we are mindful of the tougher comparatives for the second half and the continued caution in the oil and gas market, we remain well positioned for progress over the full year."

Victrex will report its interim results on Tuesday 19 May 2015.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUCPCUPAGAR
Date   Source Headline
20th May 20147:00 amRNSHalf Yearly Report
19th May 201411:57 amRNSDirector/PDMR Shareholding
30th Apr 20143:16 pmRNSTotal Voting Rights
17th Apr 20142:01 pmRNSDirector/PDMR Shareholding
10th Apr 20142:49 pmRNSHolding(s) in Company
8th Apr 20147:00 amRNSTrading Statement
3rd Apr 20141:33 pmRNSHolding(s) in Company
31st Mar 20144:25 pmRNSTotal Voting Rights
18th Mar 20144:29 pmRNSDirector/PDMR Shareholding
12th Mar 20143:08 pmRNSHolding(s) in Company
3rd Mar 201410:18 amRNSHolding(s) in Company
28th Feb 20142:00 pmRNSTotal Voting Rights
19th Feb 20145:04 pmRNSDirector/PDMR Shareholding
18th Feb 201412:01 pmRNSDirector/PDMR Shareholding
4th Feb 20142:17 pmRNSResult of AGM
4th Feb 20147:00 amRNSAGM and Q1 Interim Management Statement
31st Jan 20143:30 pmRNSDirectorate Change
31st Jan 20149:00 amRNSTotal Voting Rights
17th Jan 201410:07 amRNSDirector/PDMR Shareholding
15th Jan 20144:42 pmRNSHolding(s) in Company
14th Jan 20143:06 pmRNSDirector/PDMR Shareholding
2nd Jan 201411:37 amRNSAnnual Financial Report
31st Dec 20137:00 amRNSTotal Voting Rights
17th Dec 20135:17 pmRNSDirector/PDMR Shareholding
17th Dec 20134:47 pmRNSDirector/PDMR Shareholding
17th Dec 201311:36 amRNSDirector/PDMR Shareholding
13th Dec 20133:14 pmRNSHolding(s) in Company
10th Dec 20137:00 amRNSFinal Results
2nd Dec 20134:19 pmRNSBlocklisting Interim Review
29th Nov 20138:39 amRNSTotal Voting Rights
19th Nov 20132:16 pmRNSDirector/PDMR Shareholding
13th Nov 20133:33 pmRNSDirector Declaration
7th Nov 20137:00 amRNSDirectorate Change
31st Oct 20132:47 pmRNSTotal Voting Rights
25th Oct 201311:46 amRNSHolding(s) in Company
17th Oct 20132:31 pmRNSDirector/PDMR Shareholding
14th Oct 20133:51 pmRNSHolding(s) in Company
14th Oct 20133:48 pmRNSHolding(s) in Company
10th Oct 20137:00 amRNSInvestor Day
8th Oct 20137:00 amRNSTrading Statement
1st Oct 20134:31 pmRNSHolding(s) in Company
30th Sep 20132:56 pmRNSTotal Voting Rights
17th Sep 20133:35 pmRNSDirector/PDMR Shareholding
11th Sep 20133:45 pmRNSHolding(s) in Company
4th Sep 20138:42 amRNSDirector Declaration
30th Aug 20131:53 pmRNSHolding(s) in Company
30th Aug 20138:33 amRNSTotal Voting Rights
19th Aug 20134:07 pmRNSDirector/PDMR Shareholding
2nd Aug 20138:48 amRNSHolding(s) in Company
29th Jul 20137:56 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.